ロード中...
The development of an oral GLP-1 receptor agonist for the management of type 2 diabetes: evidence to date
Glucagon-like peptide 1 receptor agonists (GLP1-RA) are prominent agents in the therapeutics of type 2 diabetes mellitus due to their exemplary efficacy in both preprandial and postprandial glycemia, their safety, low risk of hypoglycemia, their multilevel pathophysiological superiority, weight loss...
保存先:
| 出版年: | Drug Des Devel Ther |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6709822/ https://ncbi.nlm.nih.gov/pubmed/31686781 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S166765 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|